Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Koch

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Plos Pathogens|May 7, 2019
Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expressionSandra Koch, Modester Damas, Anika Freise, et al.
BMC Cancer|April 29, 2018
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaAline Mähringer-Kunz, Arndt Weinmann, Irene Schmidtmann, et al.
Journal of Clinical Gastroenterology|July 12, 2014
Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patientsArndt Weinmann, Thomas Sattler, Hans-Peter Unold, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 28, 2012
The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenibMarcus A Wörns, Sandra Koch, Ina M Niederle, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2013
Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agentsJens M Kittner, Nora M Weiss, Jörg Wiltink, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
Foods (Basel, Switzerland)|May 13, 2026
In Vitro TLR4 Stimulating Bioactivities of Amylase/Trypsin-Inhibitors from Wheat (<i>Triticum aestivum</i> L.) Bred from 1891 to 2010Manjusha Neerukonda, Sabrina Geisslitz, Darina Pronin, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
BMC Cancer|August 2, 2018
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohortYvonne Huber, Franziska Bierling, Christian Labenz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2018
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?Aline Mähringer-Kunz, Verena Steinle, Christoph Düber, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Plos Pathogens|May 7, 2019
Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expressionSandra Koch, Modester Damas, Anika Freise, et al.
BMC Cancer|April 29, 2018
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaAline Mähringer-Kunz, Arndt Weinmann, Irene Schmidtmann, et al.
Journal of Clinical Gastroenterology|July 12, 2014
Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patientsArndt Weinmann, Thomas Sattler, Hans-Peter Unold, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 28, 2012
The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenibMarcus A Wörns, Sandra Koch, Ina M Niederle, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2013
Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agentsJens M Kittner, Nora M Weiss, Jörg Wiltink, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
Foods (Basel, Switzerland)|May 13, 2026
In Vitro TLR4 Stimulating Bioactivities of Amylase/Trypsin-Inhibitors from Wheat (<i>Triticum aestivum</i> L.) Bred from 1891 to 2010Manjusha Neerukonda, Sabrina Geisslitz, Darina Pronin, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
BMC Cancer|August 2, 2018
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohortYvonne Huber, Franziska Bierling, Christian Labenz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 16, 2018
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?Aline Mähringer-Kunz, Verena Steinle, Christoph Düber, et al.
Pageof 5